Generation of Highly Selective VPAC2 Receptor Agonists by High Throughput Mutagenesis of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Peptide
Open Access
- 1 March 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (12) , 10273-10281
- https://doi.org/10.1074/jbc.m211945200
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Origin and Function of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)/Glucagon SuperfamilyEndocrine Reviews, 2000
- Production, analysis and bioactivity of recombinant vasoactive intestinal peptide analogsBiochimie, 1996
- Structure-Activity Relationship Studies of PACAP-27 and VIP AnaloguesAnnals of the New York Academy of Sciences, 1996
- Effect of introduction of an Arginine16 in VIP, PACAP and secretin on ligand affinity for the receptorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- CREATIONISM, IDEOLOGY, AND SCIENCEAnnals of the New York Academy of Sciences, 1995
- Solution structure of pituitary adenylate cyclase activating polypeptide by nuclear magnetic resonance spectroscopyBiochemistry, 1993
- A Thermodynamic Scale for the Helix-Forming Tendencies of the Commonly Occurring Amino AcidsScience, 1990
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989
- Solution structure of an analog of vasoactive intestinal peptide as determined by two-dimensional NMR and circular dichroism spectroscopies and constrained molecular dynamicsBiochemistry, 1989
- Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptideEuropean Journal of Biochemistry, 1988